Suchergebnisse - "Hasselbalch, Hans Carl"

PubPharm (9)

1

Smoking impairs molecular response, and reduces overall survival in patients with chronic myeloproliferative neoplasms : A retrospective cohort study

enthalten in: British journal of haematology | 2021

von Sørensen, A. | Knudsen, T. | Skov, V. | +4

2

A new era for IFN-α in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms

enthalten in: Expert review of hematology | 2011

von Hasselbalch, H.

3

Increase in circulating CD4⁺CD25⁺Foxp3⁺ T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α

enthalten in: Blood | 2011

von Riley, C. | Jensen, M. | Brimnes, M. | +4

4

Interferon-alpha in the treatment of Philadelphia-negative chronic myeloproliferative neoplasms. Status and perspectives

enthalten in: Current drug targets | 2011

von Hasselbalch, H. | Larsen, T. | Riley, C. | +2

5

Interferon alpha2 in the treatment of hematological malignancies. Status and perspectives

enthalten in: Current drug targets | 2011

von Hasselbalch, H.

6

Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remission

enthalten in: Hematology (Amsterdam, Netherlands) | 2009

von Larsen, T. | Møller, M. | de Stricker, K. | +6

7

Novel medical treatment modalities in hematology

enthalten in: Ugeskrift for laeger | 2008

von Hasselbalch, H. | Birgens, H. | Dufva, I. | +4

8

Rituximab. A monoclonal CD20 antibody--hematological indications and possible treatments for immunoinflammatory diseases

enthalten in: Ugeskrift for laeger | 2004

von Hansen, P. | Hasselbalch, H.

9

STI571 (Glivec)--a new drug for the treatment of chronic myeloid leukemia

enthalten in: Ugeskrift for laeger | 2002

von Hasselbalch, H.

1
[1]